Direkt zum Inhalt
Merck
  • HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance.

HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance.

Nature communications (2014-08-08)
Huai-Chia Chuang, Wayne H-H Sheu, Yi-Ting Lin, Ching-Yi Tsai, Chia-Yu Yang, Yu-Jhen Cheng, Pau-Yi Huang, Ju-Pi Li, Li-Li Chiu, Xiaohong Wang, Min Xie, Michael D Schneider, Tse-Hua Tan
ZUSAMMENFASSUNG

Proinflammatory cytokines play important roles in insulin resistance. Here we report that mice with a T-cell-specific conditional knockout of HGK (T-HGK cKO) develop systemic inflammation and insulin resistance. This condition is ameliorated by either IL-6 or IL-17 neutralization. HGK directly phosphorylates TRAF2, leading to its lysosomal degradation and subsequent inhibition of IL-6 production. IL-6-overproducing HGK-deficient T cells accumulate in adipose tissue and further differentiate into IL-6/IL-17 double-positive cells. Moreover, CCL20 neutralization or CCR6 deficiency reduces the Th17 population or insulin resistance in T-HGK cKO mice. In addition, leptin receptor deficiency in T cells inhibits Th17 differentiation and improves the insulin sensitivity in T-HGK cKO mice, which suggests that leptin cooperates with IL-6 to promote Th17 differentiation. Thus, HGK deficiency induces TRAF2/IL-6 upregulation, leading to IL-6/leptin-induced Th17 differentiation in adipose tissue and subsequent insulin resistance. These findings provide insight into the reciprocal regulation between the immune system and the metabolism.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Dexamethason, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Dexamethason, ≥98% (HPLC), powder
Sigma-Aldrich
Dexamethason, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Supelco
Dexamethason, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Dexamethason, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Dexamethason, meets USP testing specifications
Sigma-Aldrich
Dexamethason, tested according to Ph. Eur.
Dexamethason für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Dexamethason, European Pharmacopoeia (EP) Reference Standard
Dexamethason für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Supelco
Dexamethason, VETRANAL®, analytical standard
Dexamethason, British Pharmacopoeia (BP) Assay Standard